Cargando…
Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial
BACKGROUND: A randomized controlled trial of adults with empyema recently demonstrated decreased length of stay in hospital in patients treated with intrapleurally administered dornase alfa and fibrinolytics compared to fibrinolytics alone. Whether this treatment strategy is safe and effective in ch...
Autores principales: | Livingston, Michael H., Mahant, Sanjay, Ratjen, Felix, Connolly, Bairbre L., Thorpe, Kevin, Mamdani, Muhammad, Maclusky, Ian, Laberge, Sophie, Giglia, Lucy, Walton, J. Mark, Yang, Connie L., Roberts, Ashley, Shawyer, Anna C., Brindle, Mary, Parsons, Simon J., Stoian, Cristina A., Cohen, Eyal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5482972/ https://www.ncbi.nlm.nih.gov/pubmed/28646887 http://dx.doi.org/10.1186/s13063-017-2026-0 |
Ejemplares similares
-
Intrapleural Tissue Plasminogen Activator and Dornase Alfa Administration for a Multiloculated Recurrent Malignant Pleural Effusion: A Case Report
por: Nikoomanesh, Kia, et al.
Publicado: (2022) -
Rethinking the Doses of Tissue Plasminogen Activator and Deoxyribonuclease Administrated Concurrently for Intrapleural Therapy for Complicated Pleural Effusion and Empyema
por: Innabi, Ayoub, et al.
Publicado: (2018) -
VATS and Intrapleural Fibrinolytic Therapy for Parapneumonic Empyema
por: Ohara, Gen, et al.
Publicado: (2018) -
Intrapleural therapy in management of complicated parapneumonic effusions and empyema
por: Ahmed, AlaEldin H, et al.
Publicado: (2010) -
Tuberculous empyema: combined intrapleural therapy might be an alternative
por: Colares, Philippe de Figueiredo Braga, et al.
Publicado: (2022)